These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34358031)

  • 1. The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy.
    Zhang Z; Zhang G; Guo M; Tao W; Liu X; Wei H; Jin T; Zhang Y; Zhu S
    Pathogens; 2021 Jul; 10(7):. PubMed ID: 34358031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
    Jalkanen P; Pasternack A; Maljanen S; Melén K; Kolehmainen P; Huttunen M; Lundberg R; Tripathi L; Khan H; Ritvos MA; Naves R; Haveri A; Österlund P; Kuivanen S; Jääskeläinen AJ; Kurkela S; Lappalainen M; Rantasärkkä K; Vuorinen T; Hytönen J; Waris M; Tauriainen S; Ritvos O; Kakkola L; Julkunen I
    J Infect Dis; 2021 Jul; 224(2):218-228. PubMed ID: 33905505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
    Beaudoin-Bussières G; Laumaea A; Anand SP; Prévost J; Gasser R; Goyette G; Medjahed H; Perreault J; Tremblay T; Lewin A; Gokool L; Morrisseau C; Bégin P; Tremblay C; Martel-Laferrière V; Kaufmann DE; Richard J; Bazin R; Finzi A
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity.
    van Keulen BJ; Romijn M; Bondt A; Dingess KA; Kontopodi E; van der Straten K; den Boer MA; Burger JA; Poniman M; Bosch BJ; Brouwer PJM; de Groot CJM; Hoek M; Li W; Pajkrt D; Sanders RW; Schoonderwoerd A; Tamara S; Timmermans RAH; Vidarsson G; Stittelaar KJ; Rispens TT; Hettinga KA; van Gils MJ; Heck AJR; van Goudoever JB
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain.
    Secchi M; Bazzigaluppi E; Brigatti C; Marzinotto I; Tresoldi C; Rovere-Querini P; Poli A; Castagna A; Scarlatti G; Zangrillo A; Ciceri F; Piemonti L; Lampasona V
    J Clin Invest; 2020 Dec; 130(12):6366-6378. PubMed ID: 32991329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
    Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
    Front Immunol; 2021; 12():664619. PubMed ID: 34305895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics and significance of the antibody response to SARS-CoV-2 infection.
    Iyer AS; Jones FK; Nodoushani A; Kelly M; Becker M; Slater D; Mills R; Teng E; Kamruzzaman M; Garcia-Beltran WF; Astudillo M; Yang D; Miller TE; Oliver E; Fischinger S; Atyeo C; Iafrate AJ; Calderwood SB; Lauer SA; Yu J; Li Z; Feldman J; Hauser BM; Caradonna TM; Branda JA; Turbett SE; LaRocque RC; Mellon G; Barouch DH; Schmidt AG; Azman AS; Alter G; Ryan ET; Harris JB; Charles RC
    medRxiv; 2020 Jul; ():. PubMed ID: 32743600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
    Figueiredo-Campos P; Blankenhaus B; Mota C; Gomes A; Serrano M; Ariotti S; Costa C; Nunes-Cabaço H; Mendes AM; Gaspar P; Pereira-Santos MC; Rodrigues F; Condeço J; Escoval MA; Santos M; Ramirez M; Melo-Cristino J; Simas JP; Vasconcelos E; Afonso Â; Veldhoen M
    Eur J Immunol; 2020 Dec; 50(12):2025-2040. PubMed ID: 33084029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection.
    Ramos I; Goforth C; Soares-Schanoski A; Weir DL; Samuels EC; Phogat S; Meyer M; Huang K; Pietzsch CA; Ge Y; Pike BL; Regeimbal J; Simons MP; Termini MS; Vangeti S; Marjanovic N; Lizewski S; Lizewski R; George MC; Nair VD; Smith GR; Mao W; Chikina M; Broder CC; Laing ED; Bukreyev A; Sealfon SC; Letizia AG
    Front Immunol; 2021; 12():681586. PubMed ID: 34177926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19.
    Varadhachary A; Chatterjee D; Garza J; Garr RP; Foley C; Letkeman A; Dean J; Haug D; Breeze J; Traylor R; Malek A; Nath R; Linbeck L
    medRxiv; 2020 Aug; ():. PubMed ID: 32817976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.
    Schaffner A; Risch L; Aeschbacher S; Risch C; Weber MC; Thiel SL; Jüngert K; Pichler M; Grossmann K; Wohlwend N; Lung T; Hillmann D; Bigler S; Bodmer T; Imperiali M; Renz H; Kohler P; Vernazza P; Kahlert CR; Twerenbold R; Paprotny M; Conen D; Risch M
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
    Chen Y; Tong X; Li Y; Gu B; Yan J; Liu Y; Shen H; Huang R; Wu C
    PLoS Pathog; 2020 Sep; 16(9):e1008796. PubMed ID: 32913364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
    Indenbaum V; Koren R; Katz-Likvornik S; Yitzchaki M; Halpern O; Regev-Yochay G; Cohen C; Biber A; Feferman T; Cohen Saban N; Dhan R; Levin T; Gozlan Y; Weil M; Mor O; Mandelboim M; Sofer D; Mendelson E; Lustig Y
    PLoS One; 2020; 15(11):e0241164. PubMed ID: 33227020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.
    Brynjolfsson SF; Sigurgrimsdottir H; Einarsdottir ED; Bjornsdottir GA; Armannsdottir B; Baldvinsdottir GE; Bjarnason A; Gudlaugsson O; Gudmundsson S; Sigurdardottir ST; Love A; Kristinsson KG; Ludviksson BR
    Front Immunol; 2021; 12():695230. PubMed ID: 34177962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.